Chinese Journal of Tissue Engineering Research ›› 2024, Vol. 28 ›› Issue (1): 56-61.doi: 10.12307/2024.103

Previous Articles     Next Articles

Recombinant human growth hormone promotes osteogenic differentiation of human dental pulp stem cells

Sun Jing1, Liao Jian1, Sun Jiangling2, Cheng Ping2, Feng Hongchao1, 2   

  1. 1School of Stomatology of Guizhou Medical University, Guiyang 550004, Guizhou Province, China; 2Guiyang Stomatology Hospital, Guiyang 550002, Guizhou Province, China
  • Received:2023-01-30 Accepted:2023-03-04 Online:2024-01-08 Published:2023-06-28
  • Contact: Feng Hongchao, MD, Professor, Chief physician, School of Stomatology of Guizhou Medical University, Guiyang 550004, Guizhou Province, China; Guiyang Stomatology Hospital, Guiyang 550002, Guizhou Province, China
  • About author:Sun Jing, Master candidate, School of Stomatology of Guizhou Medical University, Guiyang 550004, Guizhou Province, China
  • Supported by:
    Science and Technology Fund Project of Guizhou Provincial Health Commission, No. gzwkj2022-431 (to FHC)

Abstract: BACKGROUND: Previous studies have shown that human dental pulp stem cells have good osteogenic differentiation potential and are potential seed cells in bone tissue engineering, and the effect of recombinant human growth hormone on the proliferative osteogenic differentiation of human dental pulp stem cells is still unclear.
OBJECTIVE: To explore the effect of recombinant human growth hormone on the proliferation and osteogenic differentiation of human dental pulp stem cells.
METHODS: Human dental pulp stem cells were isolated and cultured by tissue block culture method. After screening according to the drug concentration gradient, recombinant human growth hormone containing 10, 100, 250, 500, 1 000 μg/L was selected as the experimental group, and 0 μg/L without recombinant human growth hormone was selected as the control group. CCK-8 detection reagents were used on days 1, 3, 5, and 7 after the drug intervention to detect the proliferation of human dental pulp stem cells. Different concentrations (10, 100, 250, 500, and 1 000 μg/L) of recombinant human growth hormone were added to the osteogenesis induction solution to intervene in human dental pulp stem cells. Alkaline phosphatase activity was detected by alkaline phosphatase staining and semi-quantitative analysis on day 7 of mineralization induction. The mRNA expression levels of osteogenic gene type I collagen, osteocalcin and Runt-related transcription factor 2 were detected by fluorescence quantitative RT-qPCR. Alizarin red staining was performed on day 14 of mineralization induction to detect osteogenic mineralized nodules.  
RESULTS AND CONCLUSION: (1) CCK-8 assay results showed that from the third day of intervention, the 100, 250, 500, 1 000 μg/L recombinant human growth hormone group could promote the proliferation of human dental pulp stem cells compared with the control group (P < 0.01). (2) The alkaline phosphatase activity of human dental pulp stem cells in the 100, 250, and 500 μg/L recombinant human growth hormone group was significantly increased compared with the control group (P < 0.01). The number of alizarin-stained mineralized nodules in human dental pulp stem cells in the 100, 250 μg/L recombinant human growth hormone group was significantly increased compared with the control group (P < 0.01). Compared with the control group, the mRNA expression of type I collagen and osteocalcin increased in the 250 μg/L recombinant human growth hormone group (P < 0.05, P < 0.01). mRNA expression of Runt-associated transcription factor 2 increased in the 100 and 250 μg/L recombinant human growth hormone groups (P < 0.01). (3) According to the above results, recombinant human growth hormone at a concentration of 250 μg/L is a more suitable concentration to promote the proliferation and osteogenic differentiation of human dental pulp stem cells.

Key words: mesenchymal stem cell, human dental pulp stem cell, growth hormone, recombinant human growth hormone, cell proliferation, osteogenesis, differentiation

CLC Number: